High SARS-CoV-2 Seroprevalence in Children and Adults in the Austrian Ski Resort Ischgl. Preprint
GHDx Entry last modified on: Mar 14, 2022
COVID-19
Dataset Records for COVID-19
Displaying 1001 - 1050 of 1564
Mass SARS-CoV-2 serological screening for the Principality of Andorra. Preprint
GHDx Entry last modified on: Feb 12, 2024
Seroprevalence of antibodies against SARS-CoV-2 among public community and health-care workers in Alzintan City of Libya. Preprint
GHDx Entry last modified on: Mar 14, 2022
Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic
GHDx Entry last modified on: Jan 31, 2024
Brazil - Rio Grande do Norte COVID-19 Epidemiological Report 2021
Informe Epidemiológico Coronavírus (Covid-19)
Seropositive Prevalence of Antibodies Against SARS-CoV-2 in Wuhan, China
GHDx Entry last modified on: Jan 31, 2024
Serology- and PCR-based cumulative incidence of SARS-CoV-2 infection in adults in a successfully contained early hotspot (CoMoLo study), Germany, May to June 2020
GHDx Entry last modified on: Jan 31, 2024
Searching for COVID-19 Antibodies in Czech Children-A Needle in the Haystack
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Juba, South Sudan: a population-based study
GHDx Entry last modified on: Mar 14, 2022
A Single-centre Study of COVID-19 Antibody
GHDx Entry last modified on: Mar 14, 2022
Low seroprevalence of COVID-19 in Lao PDR, late 2020
GHDx Entry last modified on: Mar 14, 2022
Longitudinal SARS-CoV-2 seroprevalence in a rural and urban community household cohort in South Africa, during the first and second waves July 2020-March 2021. Preprint
GHDx Entry last modified on: May 12, 2022
Surviving COVID-19 in Bergamo province: a post-acute outpatient re-evaluation
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of COVID-19 in Taiwan revealed by testing anti-SARS-CoV-2 serological antibodies on 14,765 hospital patients
GHDx Entry last modified on: Mar 14, 2022
Armenia COVID-19 Rapid Gender Assessment Survey 2020
Survey:
Cross-sectional - Individual - Interview
Population-Based Study of anti-SARS-CoV-2, Social Distancing and Government Responses in Joinville, Brazil. Preprint
GHDx Entry last modified on: Mar 14, 2022
Risk factors and predictors that influence SARS-Cov-2 IgG positivity: A cross-sectional study of blood donors in Riyadh, Saudi Arabia
GHDx Entry last modified on: Mar 14, 2022
I SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020-January 2021
GHDx Entry last modified on: May 12, 2022
Seroprevalence of SARS-CoV-2 infection among children in Children's Hospital Zagreb during the initial and second wave of COVID-19 pandemic in Croatia
GHDx Entry last modified on: Mar 14, 2022
A cross-sectional study of immune seroconversion to SARS-CoV-2 in frontline maternity health professionals
GHDx Entry last modified on: Mar 14, 2022
Slow Spread of SARS-CoV-2 in Southern Brazil Over a 6-Month Period: Report on 8 Sequential Statewide Serological Surveys Including 35611 Participants
GHDx Entry last modified on: Jan 31, 2024
Long COVID 1 year after hospitalisation for COVID-19: a prospective bicentric cohort study
GHDx Entry last modified on: Apr 10, 2023
Maternal and perinatal characteristics and outcomes of pregnancies complicated with COVID-19 in Kuwait
GHDx Entry last modified on: Apr 10, 2023
Pregnancy and risk of COVID-19: a Norwegian registry-linkage study
GHDx Entry last modified on: Apr 10, 2023
The incidence, characteristics and outcomes of pregnant women hospitalized with symptomatic and asymptomatic SARS-CoV-2 infection in the UK from March to September 2020: A national cohort study using the UK Obstetric Surveillance System (UKOSS)
GHDx Entry last modified on: Apr 10, 2023
Sociodemographic Predictors of SARS-CoV-2 Infection in Obstetric Patients, Georgia, USA
GHDx Entry last modified on: Apr 10, 2023
Long COVID-19 syndrome: a 14-months longitudinal study during the two first epidemic peaks in Southeast Brazil
GHDx Entry last modified on: Mar 22, 2024
Natural history of long-COVID in a nationwide, population cohort study
GHDx Entry last modified on: Mar 22, 2024
One-Year Trajectory of Cognitive Changes in Older Survivors of COVID-19 in Wuhan, China: A Longitudinal Cohort Study
GHDx Entry last modified on: Mar 22, 2024
Twelve-month follow-up after hospitalization for SARS-COV-2: Physiology improves, symptoms remain
GHDx Entry last modified on: Mar 22, 2024
Prospective longitudinal evaluation of hospitalised COVID-19 survivors 3 and 12 months after discharge
GHDx Entry last modified on: Mar 22, 2024
COVID-19-associated Guillain-Barré syndrome in the early pandemic experience in Lombardia (Italy)
GHDx Entry last modified on: Oct 23, 2024
Mexico Health Secretary COVID-19 Daily Technical Report 2020
Comunicado Técnico Diario COVID-19 MÉXICO
Novel coronavirus epidemic in the Hungarian population, a cross-sectional nationwide survey to support the exit policy in Hungary
GHDx Entry last modified on: Mar 14, 2022
Results from a survey in healthy blood donors in South Eastern Italy indicate that we are far away from herd immunity to SARS-CoV-2
GHDx Entry last modified on: Mar 14, 2022
Point prevalence of SARS-CoV-2 and infection fatality rate in Orleans and Jefferson Parish, Louisiana, May 9-15, 2020. Preprint
GHDx Entry last modified on: Mar 14, 2022
The role of essential organ-based comorbidities in the prognosis of COVID-19 infection patients
GHDx Entry last modified on: Mar 14, 2022
Prevalence and reversibility of smell dysfunction measured psychophysically in a cohort of COVID-19 patients
GHDx Entry last modified on: Mar 14, 2022
Coronavirus disease 2019 in pregnant women: a report based on 116 cases
GHDx Entry last modified on: Jan 31, 2024
Update on clinical outcomes of women with COVID-19 during pregnancy
GHDx Entry last modified on: Jan 31, 2024
Impact of Covid-19 in pregnancy on mother's psychological status and infant's neurobehavioral development: a longitudinal cohort study in China
GHDx Entry last modified on: Mar 8, 2024
Testing of Patients and Support Persons for Coronavirus Disease 2019 (COVID-19) Infection Before Scheduled Deliveries
GHDx Entry last modified on: Jan 31, 2024
Findings from serological surveys (in August 2020) to assess the exposure of adult population to SARS Cov-2 infection in three cities of Odisha, India. Preprint.
GHDx Entry last modified on: Mar 14, 2022
Pronounced difference in Covid-19 antibody prevalence indicates cluster transmission in Stockholm, Sweden
GHDx Entry last modified on: Mar 14, 2022
New Zealand Monthly Notifiable Disease Surveillance Report, January 2021
Epi surveillance:
Subnationally representative
A longitudinal seroprevalence study in a large cohort of working adults reveals that neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independent of the severity of symptoms. Preprint
GHDx Entry last modified on: Jun 18, 2021
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Fatality Rate Among Elderly Danes: A Cross-sectional Study on Retired Blood Donors
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 Antibodies in Adults and Healthcare Workers in Southern Italy
GHDx Entry last modified on: Jan 31, 2024
SARS-CoV-2 seroprevalence and detection fraction in Utah urban populations from a probability-based sample. Preprint.
GHDx Entry last modified on: Mar 14, 2022
Subscribe